UniProtKB/Swiss-Prot P51610: Variant p.Ser2004Ile

Host cell factor 1
Gene: HCFC1
Feedback?

Variant information Variant position:

2004 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Isoleucine (I) at position 2004 (S2004I, p.Ser2004Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs6643651 [ dbSNP | Ensembl ]

Sequence information Variant position:

2004 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2035 The length of the canonical sequence.
Location on the sequence:

AARNEKGYGPATQVRWLQET S KDSSGTKPANKRPMSSPEMK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AARNEKGYGPATQVRWLQETSKDSSGTKPANKRPMSSPEMK

Mouse                         AARNEKGYGPATQVRWLQETSKDSSGTKPASKRPMSSPEMK

Rat                           AARNEKGYGPATQVRWLQETSKDSSGTKPASKRPMSSPEM-

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1020 – 2035	HCF C-terminal chain 1
Chain	1082 – 2035	HCF C-terminal chain 2
Chain	1111 – 2035	HCF C-terminal chain 3
Chain	1296 – 2035	HCF C-terminal chain 4
Chain	1324 – 2035	HCF C-terminal chain 5
Chain	1424 – 2035	HCF C-terminal chain 6
Domain	1890 – 2006	Fibronectin type-III 3
Region	1994 – 2035	Disordered
Compositional bias	1997 – 2015	Polar residues
Modified residue	2005 – 2005	N6-acetyllysine
Cross	2024 – 2024	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Alternative sequence	429 – 2035	Missing. In isoform 3.

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.